sacituzumab govitecan,trastuzumab deruxtecan
gilead sciences,daiichi sankyo,astrazeneca
['sacituzumab govitecan', 'sequence', 'tropics02']
#tropics02 explored sacituzumab govitecan vs tpc in hr+bc #asco22 pfs better w/saci, os immature safety c/w prior data in heavily pretx population, this is great on eve of db04, w/many of these pts eligible for tdxd, hard to know where it falls in sequence 
Director Breast Oncology, Lifespan Cancer Institute, Legorreta Cancer Center Brown Univ | Medical Advisor @drloveresearch | #bcsm #clinicaltrials | Views Mine